Annual report pursuant to Section 13 and 15(d)

Note 18 - Fair Values of Financial Instruments (Details Textual)

v3.21.1
Note 18 - Fair Values of Financial Instruments (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses $ 0 $ 0
Available-for-sale Securities, Amortized Cost Basis, Total 2,200  
Impaired Financing Receivable, Recorded Investment, Total 11,800 7,200
Impaired Financing Receivable, Related Allowance 1,800 166
Impaired Financing Receivable, Fair Value $ 10,000 $ 7,100